Medicare Enrolled
Dr. Jodi Kresch, D.O.
Neurology · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kresch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kresch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kresch
Dr. Jodi Kresch is a neurology specialist in Rochester Hills, MI, with 17 years of NPI registration. Based on federal Medicare data, Dr. Kresch performed 979 Medicare services across 758 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kresch received a total of $14,718 from 77 pharmaceutical and/or device companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kresch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 17% volume in MI
$14,718 industry payments
Medicare Practice Summary
Medicare Utilization ↗979
Medicare services
Top 17% in MI for neurology
758
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
395 | $91 | $164 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
211 | $63 | $102 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
184 | $134 | $287 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
73 | $94 | $147 |
| New patient office visit, complex (60-74 min) | 50 | $169 | $306 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $106 | $196 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $117 | $238 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $59 | $112 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,718
Total received (2018-2024)
Avg $2,103/year across 7 years
Top 19% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
981
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,508 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$210 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,101
2023
$3,100
2022
$2,541
2021
$1,422
2020
$829
2019
$2,163
2018
$1,561
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$477
Celgene Corporation
$411
ABBVIE INC.
$343
TG Therapeutics, Inc.
$240
PFIZER INC.
$211
UCB, Inc.
$204
Amgen Inc.
$135
Eisai Inc.
$80
Alexion Pharmaceuticals, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$67
Genentech USA, Inc.
$67
EMD Serono, Inc.
$59
Amneal Pharmaceuticals LLC
$58
CATALYST PHARMACEUTICALS, INC.
$58
Sumitomo Pharma America, Inc.
$57
Lilly USA, LLC
$56
Octapharma USA, Inc.
$53
Biogen, Inc.
$45
Alnylam Pharmaceuticals Inc.
$41
ARGENX US, INC.
$39
Neurocrine Biosciences, Inc.
$39
SCILEX PHARMACEUTICALS INC.
$39
Lundbeck LLC
$39
JAZZ PHARMACEUTICALS INC.
$35
HARMONY BIOSCIENCES LLC
$34
Kyowa Kirin, Inc.
$32
CSL Behring
$32
Otsuka America Pharmaceutical, Inc.
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
ACADIA Pharmaceuticals Inc
$21
Neurelis, Inc.
$18
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,732
UCB, Inc.
$1,065
Celgene Corporation
$1,029
ABBVIE INC.
$1,019
GENZYME CORPORATION
$858
Supernus Pharmaceuticals, Inc.
$758
EMD Serono, Inc.
$584
Biogen, Inc.
$474
Amgen Inc.
$438
Janssen Pharmaceuticals, Inc
$411
PFIZER INC.
$394
Genentech USA, Inc.
$390
Teva Pharmaceuticals USA, Inc.
$346
Lundbeck LLC
$288
TG Therapeutics, Inc.
$240
Sunovion Pharmaceuticals Inc.
$201
Allergan Inc.
$199
Acorda Therapeutics, Inc
$194
Sumitomo Pharma America, Inc.
$191
US WorldMeds, LLC
$190
EISAI INC.
$182
AbbVie Inc.
$175
Eisai Inc.
$160
Avanir Pharmaceuticals, Inc.
$157
Takeda Pharmaceuticals U.S.A., Inc.
$137
CATALYST PHARMACEUTICALS, INC.
$136
Kyowa Kirin, Inc.
$134
JAZZ PHARMACEUTICALS INC.
$127
Neurocrine Biosciences, Inc.
$123
Horizon Therapeutics plc
$120
ACADIA Pharmaceuticals Inc
$101
Lilly USA, LLC
$101
GlaxoSmithKline, LLC.
$97
Biohaven Pharmaceutical Holding Company Ltd.
$93
Adamas Pharmaceuticals, Inc.
$85
Neurelis, Inc.
$84
Catalyst Pharmaceuticals, Inc.
$84
E.R. Squibb & Sons, L.L.C.
$83
ARGENX US, INC.
$79
Amneal Pharmaceuticals LLC
$77
BANNER LIFE SCIENCES, LLC
$74
Harmony Biosciences LLC
$73
Alexion Pharmaceuticals, Inc.
$70
Corium, LLC
$70
SK Life Science, Inc.
$69
Allergan, Inc.
$66
Biohaven Pharmaceuticals, Inc.
$64
TG THERAPEUTICS, INC.
$62
Alnylam Pharmaceuticals Inc.
$58
Octapharma USA, Inc.
$53
HARMONY BIOSCIENCES LLC
$51
Otsuka America Pharmaceutical, Inc.
$50
IMPEL PHARMACEUTICALS INC.
$45
MDD US Operations, LLC
$40
SCILEX PHARMACEUTICALS INC.
$39
Akcea Therapeutics, Inc.
$38
Grifols USA, LLC
$37
Jazz Pharmaceuticals Inc.
$35
CSL Behring
$32
Bausch Health US, LLC
$30
Zogenix Inc.
$26
Aprecia Pharmaceuticals, LLC
$26
AstraZeneca Pharmaceuticals LP
$25
Promius Pharma LLC
$24
Medtronic, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$21
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
LivaNova USA, Inc.
$21
Collegium Pharmaceutical, Inc.
$20
IDORSIA PHARMACEUTICALS US INC
$18
Boston Scientific Corporation
$18
GE HealthCare
$15
ARBOR PHARMACEUTICALS, INC.
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Cala Health, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
Upsher-Smith Laboratories LLC
$12
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · ASCENDA · AUBAGIO · AUSTEDO · Adlarity · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA TRIO · COMIRNATY · COPAXONE · CREXONT · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EVUSHELD · Enspryng · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · Ponvory · Prolia · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SUNOSI · Spritam · TEGSEDI · TRELEGY ELLIPTA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · WAKIX · Wakix · XADAGO · XLSD · XYREM · XYWAV · Xadago · Xyrem · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
247
Per 100K population
19.4
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kresch is a clinical cardiology specialist, with above-average Medicare volume (top 17% in MI), with low-engagement industry engagement in the top 19% of MI peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kresch experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kresch performed 395 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kresch receive payments from pharmaceutical companies?
Yes. Dr. Kresch received a total of $14,718 from 77 companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kresch's costs compare to other neurologists in Rochester Hills?
Dr. Kresch's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kresch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rochester Hills
Browse neurologists in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology